search
Back to results

Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD) ((AU-ROOAD))

Primary Purpose

Alzheimer Disease, Cerebral Amyloid Angiopathy

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
EVOO
OO
Sponsored by
Auburn University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Alzheimer Disease

Eligibility Criteria

55 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Men and women, experiencing mild cognitive impairment with:

  1. Mini-Mental State Exam (MMSE) scores between 18-30 (based on education level
  2. memory complaint, have objective memory loss measured by education adjusted scores on Wechsler Memory Scale Logical Memory VI
  3. Clinical Dementia Rating (CDR) score 0.5.

Exclusion Criteria:

  1. Subjects with contradictions for MRI include: the presence of metal or electronic devices such as metallic joint prostheses, artificial heart valves, an implantable heart defibrillator, a pacemaker, metal clips, cochlear implants, a bullet, shrapnel or any other type of metal fragment; breathing problems or disorders, claustrophobia, inner ear disorders, vertigo or dizziness, tattoos or permanent makeup that contains metal, and body piercing jewelry that cannot be removed.
  2. Subjects will be excluded if they are smokers
  3. Subjects who have have clinically important medical or neuropsychiatric comorbidity.
  4. Subjects who have renal problems or are allergic to the MRI contrast agent.

Sites / Locations

  • Auburn University

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

EVOO-phenol high

OO-phenol low

Arm Description

Extra-virgin olive oil rich with oleocanthal and other phenolic compounds that will be added to daily diet

Olive oil with low phenolic content that will be added to daily diet

Outcomes

Primary Outcome Measures

Effect of olive oil on the BBB intactness
Will be evaluated by DCE-MRI
Effect of olive oil on the brain activity
Will be evaluated by fMRI

Secondary Outcome Measures

Cognitive function
A battery of cognitive tasks to assess memory

Full Information

First Posted
January 28, 2019
Last Updated
July 29, 2021
Sponsor
Auburn University
search

1. Study Identification

Unique Protocol Identification Number
NCT03824197
Brief Title
Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD)
Acronym
(AU-ROOAD)
Official Title
Extra-virgin Olive Oil Prevents Mild Cognitive Impairment Conversion to Alzheimer's Disease
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Completed
Study Start Date
May 7, 2019 (Actual)
Primary Completion Date
December 31, 2020 (Actual)
Study Completion Date
December 31, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Auburn University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Until now there is no medical treatment and/or intervention that can slow, stop or reverse the underlying neurodegenerative of Alzheimer's disease (AD). The goal of this study is to demonstrate "Oleocanthal rich-extra-virgin olive oil (EVOO) consumption stops or delay mild cognitive impairment conversion to AD by restoring the blood-brain barrier (BBB) function in humans". Specific Aims: Evaluate effect of EVOO on the brain function by functional MRI (fMRI) imaging, and BBB function by dynamic contrast-enhanced MRI (DCE-MRI). Evaluate effect of EVOO on cognitive function and on selected biomarkers

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alzheimer Disease, Cerebral Amyloid Angiopathy

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
25 (Actual)

8. Arms, Groups, and Interventions

Arm Title
EVOO-phenol high
Arm Type
Other
Arm Description
Extra-virgin olive oil rich with oleocanthal and other phenolic compounds that will be added to daily diet
Arm Title
OO-phenol low
Arm Type
Other
Arm Description
Olive oil with low phenolic content that will be added to daily diet
Intervention Type
Other
Intervention Name(s)
EVOO
Other Intervention Name(s)
OC-rich EVOO
Intervention Description
Extra-virgin olive oil that is rich with oleocanthal and other phenols.
Intervention Type
Other
Intervention Name(s)
OO
Other Intervention Name(s)
Olive oil
Intervention Description
Olive oil low in oleocanthal and other phenols.
Primary Outcome Measure Information:
Title
Effect of olive oil on the BBB intactness
Description
Will be evaluated by DCE-MRI
Time Frame
6 months
Title
Effect of olive oil on the brain activity
Description
Will be evaluated by fMRI
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Cognitive function
Description
A battery of cognitive tasks to assess memory
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
55 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men and women, experiencing mild cognitive impairment with: Mini-Mental State Exam (MMSE) scores between 18-30 (based on education level memory complaint, have objective memory loss measured by education adjusted scores on Wechsler Memory Scale Logical Memory VI Clinical Dementia Rating (CDR) score 0.5. Exclusion Criteria: Subjects with contradictions for MRI include: the presence of metal or electronic devices such as metallic joint prostheses, artificial heart valves, an implantable heart defibrillator, a pacemaker, metal clips, cochlear implants, a bullet, shrapnel or any other type of metal fragment; breathing problems or disorders, claustrophobia, inner ear disorders, vertigo or dizziness, tattoos or permanent makeup that contains metal, and body piercing jewelry that cannot be removed. Subjects will be excluded if they are smokers Subjects who have have clinically important medical or neuropsychiatric comorbidity. Subjects who have renal problems or are allergic to the MRI contrast agent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amal Kaddoumi, PhD
Organizational Affiliation
Auburn University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Auburn University
City
Auburn
State/Province
Alabama
ZIP/Postal Code
36849
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD)

We'll reach out to this number within 24 hrs